These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 2108739)

  • 1. HIV-1 infection in haemophilia.
    Madhok R; Forbes CD
    Baillieres Clin Haematol; 1990 Jan; 3(1):79-101. PubMed ID: 2108739
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hemophilia and von Willebrand's disease: 2. Management. Association of Hemophilia Clinic Directors of Canada.
    CMAJ; 1995 Jul; 153(2):147-57. PubMed ID: 7600466
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Why prescribe highly purified factor VIII and IX concentrates?
    Berntorp E
    Vox Sang; 1996; 70(2):61-8. PubMed ID: 8801765
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hemophilia treatment. Predicting the long-term risk of HIV exposure by cryoprecipitate.
    Evatt B; Austin H; Leon G; Ruiz-Sáez A; de Bosch N
    Haemophilia; 2000 Jul; 6 Suppl 1():128-32. PubMed ID: 10982279
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Efficacy in viral inactivation of the concentrates of factor VIII and IX by the solvent/detergent procedure. Evaluation in patients with hemophilia].
    Guerois C; Parquet A; Vicariot M; Lecoeur FF; Maisonneuve P; Courouce AM; Dubois F; Laurian Y
    Presse Med; 1991 Jun; 20(25):1163-6. PubMed ID: 1830653
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical evaluation of viral safety of coagulation factor VIII and IX concentrates.
    Mannucci PM
    Vox Sang; 1993; 64(4):197-203. PubMed ID: 8517048
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antibody to hepatitis C (anti C 100-3) in French hemophiliacs.
    Maisonneuve P; Laurian Y; Guerois C; Verroust F; Ferrer Le Coeur F; Couroucé AM; Noel L
    Nouv Rev Fr Hematol (1978); 1991; 33(3):263-6. PubMed ID: 1956764
    [TBL] [Abstract][Full Text] [Related]  

  • 8. GB virus C/hepatitis G virus infection in HIV infected patients with haemophilia despite treatment with virus inactivated clotting factor concentrates.
    Woelfle J; Berg T; Bialek R; Keller KM; Effenberger W; Wagner N
    Arch Dis Child; 1999 May; 80(5):429-32. PubMed ID: 10208947
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Virus in hemophilia: current status and future perspectives].
    Aguilar C; Félix Lucía J
    Sangre (Barc); 1996 Apr; 41(2):141-5. PubMed ID: 9045355
    [No Abstract]   [Full Text] [Related]  

  • 10. Haemophilia.
    Cahill MR; Colvin BT
    Postgrad Med J; 1997 Apr; 73(858):201-6. PubMed ID: 9156121
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hepatitis C infection in children with hemophilia A and B.
    Blanchette VS; Vorstman E; Shore A; Wang E; Petric M; Jett BW; Alter HJ
    Blood; 1991 Jul; 78(2):285-9. PubMed ID: 1712646
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oliver Memorial Lecture 1989. The evolution and future of haemophilia therapy.
    Bloom AL
    Transfus Med; 1991 Mar; 1(1):5-12. PubMed ID: 9259820
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Has hepatitis A virus been transmitted by clotting factor concentrates among hemophiliacs in the United States?
    Mosley JW
    Vox Sang; 1994; 67 Suppl 4():12-5; discussion 24-6. PubMed ID: 7831863
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The choice of plasma-derived clotting factor concentrates.
    Mannucci PM
    Baillieres Clin Haematol; 1996 Jun; 9(2):273-90. PubMed ID: 8800505
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Haemophilia care in Zimbabwe.
    Adewuyi JO; Coutts AM; Levy L; Lloyd SE
    Cent Afr J Med; 1996 May; 42(5):153-6. PubMed ID: 8771937
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [HIV infection among type A and B hemophiliacs].
    Vicariot M; Fressinaud E; Fiks M; Fonlupt J; Berthier AM; Guerois C; Fimbel B
    Rev Fr Transfus Hemobiol; 1993 Oct; 36(5):417-26. PubMed ID: 8259952
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Prevention of transfusion-associated virus infections in hemophilic patients needing replacement therapy].
    Meili EO
    Beitr Infusionsther; 1989; 24():46-55. PubMed ID: 2481548
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hemophilia: an amazing 35-year journey from the depths of HIV to the threshold of cure.
    White GC
    Trans Am Clin Climatol Assoc; 2010; 121():61-73; discussion 74-5. PubMed ID: 20697550
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hepatitis A virus sequence detected in clotting factor concentrates associated with disease transmission.
    Robertson BH; Alter MJ; Bell BP; Evatt B; McCaustland KA; Shapiro CN; Sinha SD; Souci JM
    Biologicals; 1998 Jun; 26(2):95-9. PubMed ID: 9811512
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Low risk of transmission of the human immunodeficiency virus by a solvent-detergent-treated commercial factor VIII concentrate.
    Di Paolantonio T; Mariani G; Ghirardini A; Gringeri A; Mannucci PM; Mastrullo L; De Biasi R; Giustarini G; Morfini M; Schiavoni M
    J Med Virol; 1992 Feb; 36(2):71-4. PubMed ID: 1583469
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.